TransMedics (NSDQ:TMDX) shares took a massive hit today on first-quarter results that missed the consensus earnings forecast. TMDX shares were down -12.4% at $24.58 per share in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -1.2%. The Andover, Mass.-based organ transplant technology […]
transmedics
FDA advisory committee positive about TransMedics’ OCS Heart system
TransMedics (NSDQ:TMDX) this week said that the FDA Circulatory Systems Device Advisory Panel voted in favor of the OCS Heart System. The FDA panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh the risks. The panel also voted 10 to 6, with 2 abstaining that there is reasonable […]
TransMedics jumps on Street-beating Q4 results
TransMedics (NSDQ:TMDX) posted fourth-quarter results this week that beat the consensus forecast on Wall Street. The Andover, Mass.-based company — a maker of transplant organ preservation tech — reported losses of -$6.3 million, or -23¢ per share, on sales of $7.6 million for the three months ended Dec. 31, 2020, for a sales growth of 25% […]
MedTech 100 roundup: Stocks show no signs of slowing down
The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]
TransMedics posts Street-beating Q3 results, despite losses
TransMedics (NSDQ:TMDX) posted third-quarter results that beat the consensus forecast on Wall Street. The Andover, Mass.-based company reported losses of -$5.1 million, or -19¢ per share, on sales of $7.1 million for the three months ended Sept. 30, for a sales loss of -1.6% compared with Q3 2019. Earnings per share were -19¢, 10¢ ahead of […]
TransMedics to get its virtual day with FDA panel on heart transplant tech
After a six-month pandemic-related delay, TransMedics (NSDQ:TMDX) is set to have an FDA panel review the premarket approval application for its donor heart transport technology on October 7, 2020. TransMedics’ organ care system (OCS) technology is designed to keep donated hearts, lungs and livers in near-living condition until transplantation. The FDA approved the Andover, Mass.-based company’s […]
TransMedics beats Street earnings projections in Q2
TransMedics (NSDQ:TMDX) shares ticked slightly up today on second-quarter results that topped the consensus earnings forecast. The Andover, Mass.-based organ transplant transportation technology developer posted losses of -$8.5 million, or -36¢ per share, on sales of $3.4 million for the three months ended June 30, 2020, for a 7.6% bottom-line gain on a sales decline of […]
TransMedics proposes public offering following positive OCS Liver Protect trial results
TransMedics (NSDQ:TMDX) today announced a public offering following positive results from a clinical trial for its organ care system. The Andover, Mass.-based organ transplant transportation technology developer revealed in a news release that it is offering $60 million in shares of common stock, plus a 30-day option to purchase additional shares that total up to 15% […]
TransMedics slides on mixed Q1
TransMedics (NSDQ:TMDX) shares took a slight dip today on first-quarter results that came up mixed compared to the consensus forecast. The Andover, Mass.-based company posted losses of -$8.9 million, or -42¢ per share, on sales of $7.5 million for the three months ended March 31, 2020, for a 28.4% bottom-line slide on sales growth of 61%. […]
TransMedics gets $2.2m loan from Paycheck Protection Program
TransMedics (NSDQ:TMDX) announced that it issued a promissory note to receive more than $2.2 million under the Paycheck Protection Program (PPP). The unsecured loan with proceeds of $2,249,280 is scheduled to mature on April 20, 2022, and includes a fixed interest rate of 1% per annum, according to an SEC filing. Under the PPP, as part […]
TransMedics down on missed Q4 projections
TransMedics (NSDQ:TMDX) shares dipped today on fourth-quarter results that came up short of the consensus forecast. The Andover, Mass.–based company posted losses of -$9.2 million, or -43¢ per share, on sales of $6.1 million for the three months ended Dec. 31, 2019, for a 20.2% bottom-line slide on sales growth of 70.9%. Adjusted to exclude one-time […]
